Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Working Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year Working Capital/Sales History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 4.443.842.822.952.81

What is the latest Working Capital/Sales ratio of BAFNA PHARMACEUTICALS ?

The latest Working Capital/Sales ratio of BAFNA PHARMACEUTICALS is 4.44 based on Mar2025 Standalone results.
Year Working Capital/Sales
Mar20254.44
Mar20243.84
Mar20232.82
Mar20222.95
Mar20212.81

How is Working Capital/Sales of BAFNA PHARMACEUTICALS Trending?

Years Working Capital/Sales % Change
Mar2025 4.44
15.63
Mar2024 3.84
36.17
Mar2023 2.82
-4.41
Mar2022 2.95
4.98
Mar2021 2.81 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare Working Capital/Sales ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹362.4 Cr -2% -1.7% 91.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹414,929.0 Cr 0.7% -4.2% -8.7% Stock Analytics
DIVIS LABORATORIES ₹169,644.0 Cr 0% -1% 4% Stock Analytics
TORRENT PHARMACEUTICALS ₹131,481.0 Cr 2.4% 4.5% 14.5% Stock Analytics
CIPLA ₹122,050.0 Cr 1.1% 0.2% -1.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,784.0 Cr -1% -2% -9.7% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

-2%

-1.7%

91.7%

SENSEX

0.9%

0.7%

9.6%


You may also like the below Video Courses